DK0671943T3 - Anvendelse af enzymer, især bromelain, i behandlingen af ikke-infektiøs diarré - Google Patents

Anvendelse af enzymer, især bromelain, i behandlingen af ikke-infektiøs diarré

Info

Publication number
DK0671943T3
DK0671943T3 DK93914851T DK93914851T DK0671943T3 DK 0671943 T3 DK0671943 T3 DK 0671943T3 DK 93914851 T DK93914851 T DK 93914851T DK 93914851 T DK93914851 T DK 93914851T DK 0671943 T3 DK0671943 T3 DK 0671943T3
Authority
DK
Denmark
Prior art keywords
pct
treatment
enzymes
bromelain
infectious diarrhea
Prior art date
Application number
DK93914851T
Other languages
English (en)
Inventor
Tracey Leahanne Mynott
Original Assignee
Cortecs Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929213862A external-priority patent/GB9213862D0/en
Priority claimed from GB939308164A external-priority patent/GB9308164D0/en
Priority claimed from GB939313189A external-priority patent/GB9313189D0/en
Application filed by Cortecs Uk Ltd filed Critical Cortecs Uk Ltd
Application granted granted Critical
Publication of DK0671943T3 publication Critical patent/DK0671943T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK93914851T 1992-06-30 1993-06-30 Anvendelse af enzymer, især bromelain, i behandlingen af ikke-infektiøs diarré DK0671943T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB929213862A GB9213862D0 (en) 1992-06-30 1992-06-30 Medical use of enzymes
GB939308164A GB9308164D0 (en) 1993-04-20 1993-04-20 Medical use of enzymes
GB939313189A GB9313189D0 (en) 1993-06-25 1993-06-25 Medical use of enzymes
PCT/GB1993/001374 WO1994000147A1 (en) 1992-06-30 1993-06-30 Use of enzymes, especially bromelain, in the treatment of diarrhoea

Publications (1)

Publication Number Publication Date
DK0671943T3 true DK0671943T3 (da) 2000-03-27

Family

ID=27266268

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93914851T DK0671943T3 (da) 1992-06-30 1993-06-30 Anvendelse af enzymer, især bromelain, i behandlingen af ikke-infektiøs diarré

Country Status (13)

Country Link
US (1) US5928640A (da)
EP (1) EP0671943B1 (da)
JP (1) JPH08503691A (da)
AT (1) ATE184200T1 (da)
AU (1) AU672986B2 (da)
CA (1) CA2137674A1 (da)
DE (1) DE69326351T2 (da)
DK (1) DK0671943T3 (da)
ES (1) ES2138625T3 (da)
GR (1) GR3031961T3 (da)
NZ (1) NZ253748A (da)
SG (1) SG42846A1 (da)
WO (1) WO1994000147A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9313188D0 (en) * 1993-06-25 1993-08-11 Cortecs Ltd Medical use of enzymes
AU6303898A (en) 1997-02-25 1998-09-18 Cortecs (Uk) Limited Component of bromelain
ATE382084T1 (de) * 1997-02-25 2008-01-15 Sarantis Pty Ltd Bromelinbestandteil
US20020102253A1 (en) * 1997-02-25 2002-08-01 Mynott Tracey Lehanne Component of bromelain
ATE222121T1 (de) * 1998-07-15 2002-08-15 Ursapharm Arzneimittel Gmbh Verwendung von bromelainproteasen zur hemmung der blutgerinnung
US20010046493A1 (en) * 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
US20040166198A1 (en) * 2001-04-25 2004-08-26 Kiers Jeroen Lucas Process for the manufacture of a fermented health-promoting product
SI1809320T1 (sl) * 2004-10-14 2010-11-30 Cystic Fibrosis Foundation Therapeutics Inc Sestavki ki vsebujejo lipazo proteazo in amilazo za zdravljenje pankreasne insuficience
IL165334A0 (en) * 2004-11-22 2006-01-15 Mediwound Ltd Debriding composition from bromelain and methods of producing same
US12149618B2 (en) 2005-01-27 2024-11-19 The Chamberlain Group Llc Method and apparatus to facilitate transmission of an encrypted rolling code
US8422667B2 (en) 2005-01-27 2013-04-16 The Chamberlain Group, Inc. Method and apparatus to facilitate transmission of an encrypted rolling code
US9148409B2 (en) 2005-06-30 2015-09-29 The Chamberlain Group, Inc. Method and apparatus to facilitate message transmission and reception using different transmission characteristics
US20100196344A1 (en) * 2005-10-14 2010-08-05 Cystic Fibrosis Foundation Therapeutics, Inc. Compositions and methods for treating pancreatic insufficiency
CN108472341A (zh) * 2015-08-20 2018-08-31 安纳塔拉生命科学有限公司 具有抗炎活性的酶级分
RU2732224C9 (ru) 2016-01-31 2021-06-18 Медивунд Лтд. Раноочищающая композиция для лечения ран
US10652743B2 (en) 2017-12-21 2020-05-12 The Chamberlain Group, Inc. Security system for a moveable barrier operator
US11074773B1 (en) 2018-06-27 2021-07-27 The Chamberlain Group, Inc. Network-based control of movable barrier operators for autonomous vehicles
CA3107457A1 (en) 2018-08-01 2020-02-06 The Chamberlain Group, Inc. Movable barrier operator and transmitter pairing over a network
US10997810B2 (en) 2019-05-16 2021-05-04 The Chamberlain Group, Inc. In-vehicle transmitter training

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617417A1 (de) * 1966-12-08 1971-03-25 Ciba Geigy Pharmazeutisches Praeparat
JPS5299207A (en) * 1976-02-16 1977-08-19 Kaken Pharmaceut Co Ltd Remedy for cattle diarrhea
FR2414554A1 (fr) * 1978-01-13 1979-08-10 Steeg Lottie Nouveau milieu de culture bacterienne et ses applications comme additif alimentaire et medicament pour animaux
ATE106242T1 (de) * 1986-08-28 1994-06-15 Enzacor Pty Ltd Mikrogranuläre zubereitung zur verabreichung biologisch aktiver stoffe in den eingeweideregionen von tieren.
AU604052B2 (en) * 1986-08-28 1990-12-06 Enzacor Properties Limited Animal growth promotant
WO1993001800A1 (en) * 1991-07-24 1993-02-04 Thomas Sai Ying Ko Therapeutic compositions and methods
US5260074A (en) * 1992-06-22 1993-11-09 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
US5302400A (en) * 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids

Also Published As

Publication number Publication date
GR3031961T3 (en) 2000-03-31
DE69326351D1 (de) 1999-10-14
ES2138625T3 (es) 2000-01-16
HK1004193A1 (en) 1998-11-20
EP0671943A1 (en) 1995-09-20
EP0671943B1 (en) 1999-09-08
AU672986B2 (en) 1996-10-24
CA2137674A1 (en) 1994-01-06
ATE184200T1 (de) 1999-09-15
WO1994000147A1 (en) 1994-01-06
NZ253748A (en) 1997-06-24
US5928640A (en) 1999-07-27
JPH08503691A (ja) 1996-04-23
SG42846A1 (en) 1997-10-17
DE69326351T2 (de) 2000-05-18
AU4507493A (en) 1994-01-24

Similar Documents

Publication Publication Date Title
ES2138625T3 (es) Uso de enzimas especialmente bromelaina, en el tratamiento de diarrea no infecciosa.
ES2102813T3 (es) Composiciones farmaceuticas y dermocosmeticas que contienen calostro equino.
ES2091290T3 (es) Tratamiento para la diarrea por clostridium difficile y colitis pseudomembranosa.
DE3867853D1 (de) Mikroorganismusstamm mit antimicrobieller wirkung.
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
NO950550D0 (no) Sulfonylalkanoylamino-hydroksyetylaminosulfonamider som er nyttige som retrovirale proteaseinhibitorer
DK0755249T3 (da) Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom
ATE169445T1 (de) Verwendung von gelformulierungen als beizmittel
ES2059294T3 (es) Inhibidores de proteasas retroviricas.
ATE279519T1 (de) Antimikrobielle proteine
FI952459A0 (fi) Amidoamiinien käyttö oftalmisissa koostumuksissa
FI961054A0 (fi) Menetelmä 9-(2-hydroksi)etoksimetyyliguaniinin valmistamiseksi
ZA935660B (en) Modified proteases.
BR9007636A (pt) Bio-herbicida combinando agentes quimicos e patogenos de plantas bacterianos
ATE193206T1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
ES2155476T3 (es) Aril-tio-alquil-tio-piridinas sustituidas.
DK1033993T3 (da) Anvendelse af Escherichia coli stamme DSM 6601 i veterinærsektoren til behandling af diarré
ATE197716T1 (de) Waschmittelenzyme
DK0874718T3 (da) Anvendelse af et middel til beskyttelse af tekniske materialer mod beskadigelse og ødelæggelse på grund af skadelige organismer på basis af naturlige aktivstoffer
DK0703916T3 (da) 14-Substituerede marcfortiner og derivater, der kan anvendes som antispirant-midler
AU5625194A (en) Rectal flunisolide compositions for treating inflammatory intestinal disorders
ZA939227B (en) Novel triazoloquinazolines,their preparation and use
ATE165509T1 (de) Avermectine und milbemycine zur behandlung von parazitären infektionen beim hund
GEP19991603B (en) Iersinia Enterocolitica Bacteriophage Strain Consortium
ITMI920956A1 (it) Idrogeli superassorbenti di tipo polietereammidoaminico